MX2021014850A - Procedimiento alternativo para la preparacion de acido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il] metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5-a]pirazin-2-il]-c arboxilico. - Google Patents
Procedimiento alternativo para la preparacion de acido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il] metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5-a]pirazin-2-il]-c arboxilico.Info
- Publication number
- MX2021014850A MX2021014850A MX2021014850A MX2021014850A MX2021014850A MX 2021014850 A MX2021014850 A MX 2021014850A MX 2021014850 A MX2021014850 A MX 2021014850A MX 2021014850 A MX2021014850 A MX 2021014850A MX 2021014850 A MX2021014850 A MX 2021014850A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- sup
- phenyl
- alternative process
- dihydropyrimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a un procedimiento alternativo para la síntesis de un compuesto de fórmula (I), (ver Fórmula), R1 es fenilo, que es no sustituido o sustituido con uno, dos o tres sustituyentes seleccionados independientemente de halógeno y alquilo C1-6; R2 es alquilo C1-6; R3 es -CxH2x-; x es 1, 2, 3, 4, 5, 6 o 7; o una sal o diastereómero de aquel aceptable desde el punto de vista farmacéutico, que resulta útil para la profilaxis y el tratamiento de una enfermedad vírica en un paciente relacionado con la infección por hepatitis B o una enfermedad causada por la infección por hepatitis B.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019090358 | 2019-06-06 | ||
PCT/EP2020/065424 WO2020245246A1 (en) | 2019-06-06 | 2020-06-04 | Alternative process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021014850A true MX2021014850A (es) | 2022-01-18 |
Family
ID=71069823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021014850A MX2021014850A (es) | 2019-06-06 | 2020-06-04 | Procedimiento alternativo para la preparacion de acido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il] metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5-a]pirazin-2-il]-c arboxilico. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20220315588A1 (es) |
EP (1) | EP3980419A1 (es) |
JP (1) | JP7532420B2 (es) |
KR (1) | KR20220018486A (es) |
CN (1) | CN114026095A (es) |
AR (1) | AR119098A1 (es) |
AU (1) | AU2020288329A1 (es) |
BR (1) | BR112021024398A2 (es) |
CA (1) | CA3142659A1 (es) |
IL (1) | IL288585A (es) |
MX (1) | MX2021014850A (es) |
SG (1) | SG11202111538PA (es) |
TW (1) | TW202112781A (es) |
WO (1) | WO2020245246A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020249331A1 (en) | 2019-03-25 | 2021-09-23 | F. Hoffmann-La Roche Ag | Solid forms of a compound of HBV core protein allosteric modifier |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100348588C (zh) * | 2005-12-02 | 2007-11-14 | 浙江工业大学 | 一种嘧啶硫酮的化学合成方法 |
EP3114128B1 (en) | 2014-03-07 | 2019-01-02 | F. Hoffmann-La Roche AG | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
KR102359212B1 (ko) | 2015-03-16 | 2022-02-08 | 에프. 호프만-라 로슈 아게 | Tlr7 작용제 및 hbv 캡시드 조립 억제제를 사용하는 병용 치료 |
WO2017064156A1 (en) * | 2015-10-16 | 2017-04-20 | F. Hoffmann-La Roche Ag | Novel 6-fused and 2-heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
AR107633A1 (es) * | 2016-02-19 | 2018-05-16 | Hoffmann La Roche | Procedimiento para la preparación del ácido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxílico |
CN109153682B (zh) * | 2016-05-20 | 2021-05-25 | 豪夫迈·罗氏有限公司 | 用于治疗感染性疾病的具有氧、硫和氮连接基的新的吡嗪化合物 |
JP2021008404A (ja) * | 2017-09-27 | 2021-01-28 | アスタファーマシューティカルズ株式会社 | 変形性関節症改善剤 |
AU2018351400B2 (en) * | 2017-10-18 | 2022-12-15 | Sunshine Lake Pharma Co., Ltd. | Dihydropyrimidine compounds and uses thereof in medicine |
CN113227090A (zh) | 2018-12-20 | 2021-08-06 | 詹森药业有限公司 | 杂芳基二氢嘧啶衍生物和治疗乙型肝炎感染的方法 |
-
2020
- 2020-06-04 SG SG11202111538PA patent/SG11202111538PA/en unknown
- 2020-06-04 MX MX2021014850A patent/MX2021014850A/es unknown
- 2020-06-04 CA CA3142659A patent/CA3142659A1/en active Pending
- 2020-06-04 US US17/616,930 patent/US20220315588A1/en active Pending
- 2020-06-04 WO PCT/EP2020/065424 patent/WO2020245246A1/en active Application Filing
- 2020-06-04 EP EP20731426.1A patent/EP3980419A1/en active Pending
- 2020-06-04 AR ARP200101589A patent/AR119098A1/es unknown
- 2020-06-04 JP JP2021571985A patent/JP7532420B2/ja active Active
- 2020-06-04 AU AU2020288329A patent/AU2020288329A1/en active Pending
- 2020-06-04 BR BR112021024398A patent/BR112021024398A2/pt unknown
- 2020-06-04 CN CN202080043230.XA patent/CN114026095A/zh active Pending
- 2020-06-04 KR KR1020217039587A patent/KR20220018486A/ko unknown
- 2020-06-05 TW TW109118999A patent/TW202112781A/zh unknown
-
2021
- 2021-12-01 IL IL288585A patent/IL288585A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2020288329A1 (en) | 2021-11-18 |
SG11202111538PA (en) | 2021-11-29 |
JP2022535112A (ja) | 2022-08-04 |
AR119098A1 (es) | 2021-11-24 |
CA3142659A1 (en) | 2020-12-10 |
KR20220018486A (ko) | 2022-02-15 |
EP3980419A1 (en) | 2022-04-13 |
US20220315588A1 (en) | 2022-10-06 |
JP7532420B2 (ja) | 2024-08-13 |
IL288585A (en) | 2022-02-01 |
TW202112781A (zh) | 2021-04-01 |
BR112021024398A2 (pt) | 2022-01-18 |
WO2020245246A1 (en) | 2020-12-10 |
CN114026095A (zh) | 2022-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018009944A (es) | Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico. | |
RU2405774C2 (ru) | Гетероциклические ингибиторы аспартилпротеазы | |
MX2022014312A (es) | Inhibidores de sarcomero cardiaco. | |
RU2395500C2 (ru) | 2,4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств | |
MA41134B1 (fr) | Composés substitués de 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione pour le traitement et la prophylaxie des infections virales | |
MA41338A (fr) | Composés de pyrazine pour le traitement de maladies infectieuses | |
MX2022006475A (es) | Compuestos triciclicos sustituidos. | |
MX2021006902A (es) | Nuevos compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica. | |
MX2022015703A (es) | Compuestos para el tratamiento de enfermedades y trastornos asociados a braf. | |
WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
MX2020012827A (es) | Compuestos tetrahidro-1h-pirazino[2,1-a]isoindolilquinolina para el tratamiento de enfermedades autoinmunes. | |
CR20210513A (es) | Compuestos de haxahidro 1-h-pirazino[1,2-a]pirazina para el tratamiento de una enfermedad autoinmunitaria | |
MX2019008116A (es) | Proceso para la preparacion de compuestos de 5-amino-6h-tiazolo[4, 5-d]pirimidina-2,7-diona 3-sustituidos. | |
MX2023004745A (es) | 1,4-diazepanonas biciclicas y sus usos terapeuticos. | |
WO2020210320A8 (en) | Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones | |
EA200401519A1 (ru) | N- ациламинобензольные производные в качестве селективных ингибиторов моноаминооксидазы b | |
MX2021014850A (es) | Procedimiento alternativo para la preparacion de acido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il] metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5-a]pirazin-2-il]-c arboxilico. | |
CR20200618A (es) | Derivados de tetrahidrotienopiridina n-sustituidos y sus usos | |
WO2020251871A3 (en) | Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors | |
PL378343A1 (pl) | Pochodne benzoksazolu i ich zastosowanie jako ligandów receptora adenozyny | |
MX2023008250A (es) | Compuestos de derivados sustituidos en 4,6 de ip4. | |
TW200612912A (en) | Benzyloxy derivatives as maob inhibitors | |
CA2980653A1 (en) | 2-homopiperazine-1-yl-4h-1,3-benzothiazine-4-one derivatives and process for the preparation of 2- (homo)piperazine 1,3-benzothiazine-4-one hydrochlorides | |
MX2021012544A (es) | Compuestos novedosos y composiciones farmaceuticas de los mismos para el tratamiento de enfermedades renales. | |
MX2020011382A (es) | Derivados de tetrahidropiranoxazina que tienen actividad inhibidora de beta-secretasa 1 (bace1) selectiva. |